MONOCLONAL ANTIBODIES: A BREAKTHROUGH IN TARGETED DRUG THERAPY

Abstract

- Monoclonal antibodies (mAbs) have revolutionized modern medicine by enabling highly specific and targeted drug therapy for a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. These laboratory-engineered antibodies mimic the immune system’s natural ability to fight pathogens while minimizing damage to healthy cells. The development of monoclonal antibody therapies has led to significant advancements in precision medicine, reducing side effects and improving treatment efficacy. This paper explores the production, mechanisms, clinical applications, and future prospects of monoclonal antibodies in therapeutic interventions. Keywords: Monoclonal antibodies, targeted therapy, precision medicine, biologics, immunotherapy, cancer treatment, autoimmune diseases, drug development, antibody engineering.